Skip to main content
Category

News

GREED WATCH: GSK Announces Over $9 Billion in Revenue Growth in Q3

GSK announced it raked in more than $9 billion this quarter – an increase of over $3.5 million  over last year – during their earnings report today. While they make billions, Americans pay exorbitantly high prices for prescription drugs. GSK opposes the Biden administration reforms that lower prescription drug prices. 

  • During the call, CEO Emma Walmsley bragged about the company’s “strong and sustained performance momentum, with another quarter of double-digit sales and earnings growth.”. 
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

GREED WATCH: Pfizer Announces Double Digit Revenue Growth in Non-COVID Products

Pfizer announced it raked in $13.23 billion this quarter, growing their non-COVID operational revenues by 10%, during their earnings report today. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Pfizer opposes the Biden administration reforms that lower prescription drug prices. 

  • During the call, CFO Dave Denton bragged about the company’s success in its diversification away from COVID medicines saying, “We are extremely pleased by the strong 10% operational revenue growth of Pfizer’s non-COVID products in the third quarter of 2023… Combined with the momentum of our non-COVID product portfolio and U.S. commercialization of Paxlovid, we expect the program to yield improved operating margins this year and help drive Pfizer’s growth through the end of the decade and beyond.” 
  • Pfizer is a member of PhRMA, which is suing the Biden administration to stop Medicare from negotiating lower drug prices for patients because it would endanger their massive profits. 
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

ACA Open Enrollment Means Millions Can Sign Up for Affordable Coverage

Thanks to the Inflation Reduction Act, Millions Will Find Plans at Little to No Cost 

Washington, D.C. — Tomorrow is the first day of the 2024 open enrollment period for the Affordable Care Act (ACA) marketplaces. Over the next several weeks, millions of Americans will visit HealthCare.gov to sign up for affordable health coverage. Thanks to the work of President Biden and Democrats in Congress, the 2023 open enrollment period was the most successful in history — with almost 16 million Americans signing up for coverage. The Inflation Reduction Act’s expansion of premium tax credits as well as the Biden administration’s historic investment in the Navigator program and other initiatives to make coverage more affordable means the ACA will offer quality, affordable health care to more Americans. Eighty percent of people can now find coverage through the Marketplace for $10 or less per month.

In response, Protect Our Care Chair Leslie Dach issued the following statement:

“Thanks to President Biden and Democrats in Congress, millions of Americans can get quality and affordable health care through the ACA at little to no cost. People should go to HealthCare.gov to see if they qualify for health plans with lower premium costs – especially those who may have lost their Medicaid coverage in recent months. The Inflation Reduction Act is helping working families across the country save an average of $2,400 on their premiums, dramatically increasing the number of insured Americans and giving them more room to pay for other necessities like food, gas, and rent. Despite repeated attempts by Republicans to repeal and undermine the ACA, including taking away protections from people with pre-existing conditions, Democrats are committed to ensuring people in America have access to quality, affordable, and equitable care.” 

Background: 

FACT SHEET: ACA Marketplace Open Enrollment Starts November 1, Bringing Expanded Savings for Millions of American Families 

Thanks to the Biden Administration and Democrats in Congress, the Inflation Reduction Act Extended Premium Subsidies to Millions of Americans Through 2025

On November 1, the open enrollment period for the Affordable Care Act (ACA) marketplaces will begin. Americans have until January 16 to enroll in coverage for 2024, and those who sign up by December 15 will have coverage that starts on January 1. Several state-based marketplaces will allow for enrollment beyond this deadline. Thanks to the Inflation Reduction Act’s advanced premium tax credits championed by President Biden and Democrats in Congress, high-quality coverage through the ACA marketplaces is more affordable than ever, with four in five customers eligible for coverage costing $10 or less per month.

This open enrollment season is especially important for helping people maintain health coverage as states redetermine individuals’ Medicaid eligibility following the end of the pandemic-era continuous eligibility requirement. Many people who are no longer eligible for Medicaid coverage will be able to get low-cost, quality health coverage through the Health Insurance Marketplace. 

The open enrollment period is crucial not only for those looking for coverage, but also for families who may already be covered. At a time of rising costs, even people who already have health coverage should go to HealthCare.gov to check if more affordable plan options are available to them.

BY THE NUMBERS: Americans Will Continue to Save Big On Health Care

  • In 2023, 15.6 million people enrolled in coverage through an ACA marketplace, the highest number of Americans to ever enroll and a 38% increase (4.3 million people) since Biden took office.
  • 90 percent of people with an ACA plan are saving an average of $800 per individual and $2,400 per family on health insurance premiums as a result of the ACA’s financial assistance.
  • In 2023, 4.6 million more consumers are receiving tax credits to lower their out-of-pocket premium costs than in 2021, including 1.4 million middle income consumers who are newly eligible for lower premiums thanks to the Inflation Reduction Act.  
  • In this open enrollment, 4 in 5 consumers will be able to enroll in coverage for less than $10 per month.

How The Biden Administration And Democrats In Congress Have Reduced The Cost Of ACA Coverage

President Biden and Democrats in Congress have been laser focused on making health care more affordable for Americans. The Inflation Reduction Act lowers health care costs and expands eligibility for millions of Americans. In 2021, the American Rescue Plan expanded premium subsidy eligibility to those making over 400 percent of the federal poverty level and capped premium costs at 8.5 percent of family income across the board. The Inflation Reduction Act extends those subsidies through 2025, keeping a lifeline available for families across the country. A record 15.6 million Americans enrolled in Marketplace coverage for 2023, with 9 in 10 consumers receiving financial assistance to lower their premium costs. President Biden also finalized a fix to the “family glitch,” which allows even more families to access affordable coverage.

Capping The Amount Of Money Families Pay For Health Insurance. The Inflation Reduction Act ensures families pay no more than 8.5 percent of their income towards coverage. This helps middle income and working families, as well as older Americans who have traditionally faced excessive premiums or live in high-premium areas. Before the enhanced premium subsidies, middle income families spent an average of 15 percent of their incomes on health insurance. The subsidies are designed to benefit those who need it most, which means the higher your income, the smaller your tax credits become. A family whose health insurance premiums alone — not including deductibles — are less than 8.5 percent of their income receive no tax credits at all. 

Addressing Health Care Equity By Lowering Costs For Communities of Color. The Inflation Reduction Act’s enhanced premium subsidies, as well as substantial funding increases for Marketplace education and outreach, have boosted the number of people of color who are now covered by health insurance. Communities of color are finding health plans more affordable than ever with 53 percent more Latinos, 49 percent more Black Americans, 32 percent more American Indian and Alaska Natives enrolling in Marketplace coverage. The Biden administration has invested $98.6 million in 57 experienced Navigator organizations for the 2024 Open Enrollment Period to provide enrollment assistance to consumers, with a focus on underserved communities.

Expanding Coverage For Communities Of Color. The Center on Budget Policy and Priorities estimates the increased savings continued under the Inflation Reduction Act will cause a sharp decline in the uninsured rate across every racial group, with one in three uninsured Black adults expected to gain coverage. Prior to the American Rescue Plan, more than 11 million uninsured adults were eligible for premium tax credits, with people of color making up roughly half of the group. The premium savings continued in the Inflation Reduction Act have made more than 65 percent of uninsured Black adults eligible for zero dollar premium plans and 75 percent eligible for plans less than $50 a month. For uninsured Hispanic and Latino adults, now more than 68 percent are eligible for zero dollar premium plans and nearly 80 percent can access plans for less than $50 a month. Health coverage is imperative to reducing racial disparities across the nation. 

Eliminating Premiums For Low-Wage Workers. The Inflation Reduction Act ensures no American with an income at or below 150 percent of the federal poverty level buying their coverage on the Marketplace pays a premium.

Cutting Costs For Rural America. Thanks to the provisions in the Inflation Reduction Act, roughly 65 percent of rural Americans have access to zero dollar premium health coverage and more than 76 percent are able to find a plan for less than $50 a month, narrowing the coverage differences between rural and urban America.

Eliminating The Family Glitch. Up until recently, the “family glitch,” blocked families from receiving premium subsidies if someone in their household had access to affordable health care through employment, even if the whole family wasn’t covered by that insurance. The Biden administration’s new rule will more realistically determine what is considered affordable for families, allowing an additional 1 million people to be eligible for affordable health care on the marketplace and receive premium subsidies. 

Republicans Want To Repeal The ACA And Hike Health Care Costs

The Biden administration’s commitment to expanding affordable health coverage stands in sharp contrast to Republicans’ record on affordable health care. After more than 50 failed attempts to repeal the law, Republicans are still committed to increasing health care costs by dismantling the ACA. A recent study found that Republican hostility toward affordable health care led 3 million fewer people to enroll in coverage between 2014 and 2019, which increased average premiums by nearly 3 percent. Repealing the ACA would increase the number of uninsured Americans from 26.6 million to 61.6 million, according to 2020 data. Americans of all ages would be impacted by coverage losses. 

Attacks on the ACA continue in 2023 with Trump’s former Office of Management and Budget Chief Russ Vought’s plan to navigate debt ceiling negotiations that would have cut $2 trillion from Medicaid alone, disproportionately impacting children, people with disabilities, rural Americans, and people of color and $600 billion in cuts to the ACA, which would rip coverage from 20 million Americans and raise premiums for nearly 15 million more. In April, the Association Health Plans Act and Self Insurance Protection Act was introduced that would allow for insurers to charge more to “employers with workers that cost more to cover such as women, older people, people with chronic illnesses and pre-existing conditions and people with disabilities.” Attacks continue as Republicans just elected Mike Johnson (R-A) as Speaker of the House. Johnson has a radical health care record with his efforts to repeal the ACA, hike health care premiums, and rip away protections for people with pre-existing conditions. 

GREED WATCH: Amgen Announces Nearly $7 Billion In Q3 Earnings Report

Amgen announced it raked in $6.9 billion this quarter – a 4 percent increase over last year – during their earnings report today. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Amgen opposes the Biden administration reforms that lower prescription drug prices. 

  • During the call, CEO Robert A. Bradway bragged: “We are excited about our pipeline progress and our operating performance in the third quarter.”
  • Amgen announced it rewarded shareholders by paying a dividend in September at a rate 10% higher than the previous year.
  • Enbrel, Amgen’s blockbuster immunosuppressant drug that was selected among the first ten drugs to have lower prices negotiated by Medicare, brought in more than $1 billion in sales this quarter.
  • Amgen is part of PhRMA, which is suing the Biden administration to stop Medicare from negotiating lower drug prices for patients because it would endanger their massive profits. 
  • In Q3, Amgen also completed its acquisition of Horizon Therapeutics, a drug manufacturer specializing in rare disease drugs. Drug companies erroneously claim Medicare negotiation will threaten investment in drugs for rare diseases, but Amgen is betting a rare drug portfolio will be good for their bottom line; Amgen paid $27.8 billion for Horizon.
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

PRESS EVENT: HHS Secretary Becerra Joins Protect Our Care to Mark Beginning of 2024 Affordable Care Act Open Enrollment Period

Affordable Care Act Coverage Is More Affordable Than Ever Thanks To Expanded Tax Credits

Washington, D.C. — On Wednesday, November 1, 2023, at 9 AM ET, Department of Health and Human Services Secretary Xavier Becerra will join Protect Our Care at the Legal Aid Justice Center, an Enroll Virginia site, to mark the first day of the 2024 Affordable Care Act open enrollment period where he will participate in a press conference. At the event, Secretary Becerra will encourage Americans to sign up for quality, affordable coverage during open enrollment. Last year, a record-breaking 16.3 million people signed up for coverage through the ACA marketplaces – with around 3.6 million new registrations. 

The Biden-Harris administration has expanded premium tax credits through the Inflation Reduction Act, made historic investments in the Navigator program, and fixed the family glitch, which have expanded access to affordable coverage. These changes have also increased the number of people of color who have health coverage, which is essential to reducing racial disparities in health and economic outcomes. The Inflation Reduction Act expanded tax credits through 2025 to make coverage more affordable, reducing or eliminating out-of-pocket premiums for millions of people, and the tax credits are also available for more households than ever before. Now, 80% of people can find coverage through the Marketplace for $10 or less. These tax credits put money back in the pockets of Americans who now won’t have to make impossible choices between lifesaving health care and putting food on the table or paying rent. 

LOGISTICAL INFORMATION
Details are subject to change.

Protect Our Care and Legal Aid Justice Center Medicare Open Enrollment Press Conference

WHO:

  • Xavier Becerra, Secretary of the U.S. Department of Health and Human Services 
  • Angela Ciolfi, Executive Director of Legal Aid Justice Center 
  • Deepak Madala, Director of the Center for Healthy Communities and ENROLL Virginia!, Virginia Poverty Law Center 
  • Ruth Alburez, Navigator with Legal Aid Justice Center
  • Adriana Rossi, Patient Storyteller from Fairfax County, Virginia 
  • Health Care Provider 
  • Leslie Dach, Founder and Chair of Protect Our Care

WHERE: Legal Aid Justice Center, 6402 Arlington Blvd #1130, Falls Church, VA 22042

WHEN: Wednesday, November 1, 2023, at 9 AM ET

PRESS: RSVP to [email protected]

THIS WEEK: “Medicare is Better Than Ever” Tour Rolls On With Stops in Virginia, North Carolina, and Georgia

HHS Regional Director, State and City Officials Will Headline Events in Three States to Educate Seniors About Lower Drug Prices

Watch All Tour Stops Live Here.

Washington, D.C. — On the second week of the “Medicare is Better Than Ever” tour, Protect Our Care’s Medicare-A-Van will make stops in three states to educate seniors across the nation about new benefits thanks to legislation signed into law last year by President Biden. As seniors begin to enroll in their 2024 Medicare plans, they could save thousands of dollars on their prescription drug costs, with even more savings down the road. Over three weeks, Protect Our Care will travel to more than 10 states, make more than 25 stops, and travel over 7,000 miles.

The tour will highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act, including: 

  • Medicare negotiation for lower drug prices 
  • A $35 monthly copay cap on insulin 
  • Free shingles and other essential vaccinations
  • $2,000 out-of-pocket caps on prescription drugs beginning in 2025

Right now, the Biden administration is in the process of lowering prices for the first round of high-cost prescription drugs under the Medicare Drug Price Negotiation Program, and those prices will take effect in 2026. The first ten drugs selected for negotiation are taken by nearly 9 million people on Medicare, who spent $3.4 billion in out-of-pocket costs last year alone. This new program will lower prices for some of the highest-priced prescription drugs on the market used to treat conditions like diabetes, heart failure, blood clots, and autoimmune disorders.

MONDAY

HARRISONBURG, VIRGINIA:
WHO:
Harrisonburg Mayor Deanna Reed
Beth Bland, Executive Director of the Valley Program for Aging Services
Betty Tabony, storyteller

WHERE: Ralph Sampson Park, 431 E Washington St, Harrisonburg, VA 22802

WHEN: Monday, October 30, 2023 at 11:00 AM ET

TUESDAY

ROANOKE, VIRGINIA:
WHO:
Roanoke Mayor Sherman Lea
Delegate Sam Rasoul
Ron Boyd, President & Chief Executive Officer of the Local Office on Aging
Robbie Boyd, LTC Ombudsman at the Local Office on Aging

WHERE: Martin Luther King Jr. Memorial, 1st St NW, Roanoke, VA 24016

WHEN: Tuesday, October 31, 2023 at 1:00 PM ET

WEDNESDAY

RALEIGH, NORTH CAROLINA:
WHO:
State Representative Sarah Crawford
Carla West, Senior Director for Human Services, Division of Aging and Adult Services, NC DHHS
Two Retired School Personnel Members

WHERE: Moore Square Park, 201 S Blount St, Raleigh, NC 27601

WHEN: Wednesday, November 01, 2023 at TBA

GREENSBORO, NORTH CAROLINA:
WHO:
Two Retired School Personnel Members

WHERE: TBA

WHEN: Wednesday, November 01, 2023 at TBA

THURSDAY

ATLANTA, GEORGIA:
WHO:
HHS Regional Director
Fulton County Board of Commissioners Chairman Rob Pitts
A Representative from the Centers for Medicare & Medicaid Services
A Representative from the Office of Representative Nikema Williams (D-GA-05)

WHERE: H.J.C. Bowden Senior Multipurpose Facility, 2885 Church St, East Point, GA 30344

WHEN: Thursday, November 02, 2023 at TBA

FRIDAY
LITHONIA, GEORGIA:
WHO:
A Representative from the Office of Representative Hank Johnson (D-GA-04)

WHERE: Lou Walker Senior Center, 2538 Panola Rd, Lithonia, GA 30058

WHEN: Friday, November 03, 2023 at 11:00 AM ET

Week One: “Medicare is Better Than Ever” Tour Rolled Into New York, Pennsylvania, Michigan, Wisconsin

Lieutenant Governor, HHS Regional Directors, State and City Officials Headlined “Medicare is Better Than Ever” Tour Events to Educate Seniors About Lower Drug Prices

On the first week of Protect Our Care’s 7,000-mile “Medicare is Better Than Ever” tour, the Medicare-A-Van made stops in four states to educate seniors across the nation about new benefits thanks to legislation signed into law last year by President Biden. As seniors begin to enroll in their 2024 Medicare plans, they could save thousands of dollars on their prescription drug costs, with even more savings down the road.

During each stop, local elected officials, health care advocates, and storytellers discussed how the Inflation Reduction Act will improve care and lower costs for American seniors. Protect Our Care also made headlines across the nation educating seniors on the new benefits under the Inflation Reduction Act, including free vaccines, $35 insulin caps, protections from outrageous price hikes, and lower drug costs thanks to Medicare negotiation. 

Next week, the tour continues in Virginia, North Carolina, and Georgia. Over three weeks, the Medicare-A-Van will travel to more than 10 states, make more than 25 stops, and travel over 7,000 miles.

Watch All Tour Stops Here

Syracuse, New York

State Senator John Mannion and Syracuse Common Council President Helen Hudson joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at Syracuse City Hall to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

  • Spectrum News CNY: Protect Our Care Medicare is Better Than Ever Van Tour Stops in Syracuse

Watch the event here.

New Windsor, New York

State Senator James Skoufis joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Marasco Senior Center in New Windsor to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

  • MidHudson News: Protect Our Care’s Medicare is Better Than Ever tour rolls into Orange County
  • News12 Westchester: Protect Our Care Medicare is Better Than Ever Van Tour Stops in Westchester

Watch the event here.

Westchester, New York

Westchester County Executive George Latimer and HHS Regional Director Dara Kass joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Theodore D. Young Community Center in White Plains to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

Watch the event here.

Scranton, Pennsylvania

Scranton Mayor Paige Cognetti joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at Sheeley’s Drug Store in Scranton to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Watch the event here.

Harrisburg, Pennsylvania

Lieutenant Governor Austin Davis joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Heinz-Menaker Senior Center in Harrisburg to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

  • WGAL (NBC): Medicare is Better Than Ever in Harrisburg
  • WMPT (FOX): Medicare is Better Than Ever in Harrisburg
  • PACast: Medicare is Better Than Ever Tour in Harrisburg
  • 21News (CBS): Medicare is Better Than Ever Tour Touts Savings for Seniors
  • WGAL (NBC): Event touts Medicare improvements that could help seniors save thousands on prescription drugs

Watch the event here.

Flint, Michigan

HHS Regional Director Michael Cabonargi joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Brennan Senior Center in Flint to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

Watch the event here.

Lansing, Michigan

HHS Regional Director Michael Cabonargi joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Michigan State Capitol in Lansing to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

  • WLAJ (ABC): Medicare is Better Than Ever Tour Visits Lansing
  • WILX (NBC): Medicare Helpers Tour The Nation

Watch the event here.

Madison, Wisconsin

HHS Regional Director Michael Cabonargi joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Goodman Community Center in Madison to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Watch the event here.

Milwaukee, Wisconsin

HHS Regional Director Michael Cabonargi joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Washington Park Senior Center in Milwaukee to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Watch the event here.

Additional “Medicare Autumn” Coverage

National

Maryland

  • WBFF: Medicare Open Enrollment Brings New Benefits and Savings for Millions of Seniors

Michigan

Oklahoma

  • KOKH: Seniors to Experience Relief in 2024: New Savings on Skyrocketing Prescription Drug Costs

Tennessee

  • WTVC: Seniors to Experience Prescription Drug Cost Relief in 2024

Utah

  • KUTV: New Benefits for Seniors During Open Enrollment

Wisconsin

GREED WATCH: AbbVie Announces Nearly $14 Billion In Q3 Revenue Report, Beating Estimates and Raising Future Growth Expectations

This morning, AbbVie announced it raked in over $13.9 billion in the third quarter of 2023 – $24 million more than expected – during their earnings report. While they make billions, Americans pay exorbitantly high prices for prescription drugs. AbbVie opposes the Biden administration reforms that lower prescription drug prices.

  • During the call, CEO Rick Gonzales bragged about the company’s strong growth platform: “I’m extremely pleased with our continued strong momentum and execution across our business. Our growth platform is substantially outperforming our expectations.”
  • AbbVie announced it is rewarding its shareholders with a 4.7 percent dividend increase, payable in February 2024.
  • Imbruvica, AbbVie’s blockbuster leukemia drug that was selected among the first ten drugs to have lower prices negotiated by Medicare, brought in more than $900 million this quarter.
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

GREED WATCH: Merck Announces Over One Billion More Revenue This Quarter Than Last Year

Merck announced it raked in $16 billion this quarter – a $1.04 billion increase over last year – during their earnings report. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Merck opposes the Biden administration reforms that lower prescription drug prices. 

  • During the call, CEO Rob Davis bragged about the company’s “We remain committed to our dividend and plan to increase it over time. Business development continues to be a high priority. Our track record demonstrates our ability to identify compelling science and technologies that have the potential… to rapidly progress the opportunities for the benefit of… our shareholders.”
  • Merck announced it is rewarding its shareholders with $338 million in stock buybacks over just this past quarter. 
  • Merck is suing the Biden administration to stop Medicare from negotiating lower drug prices for patients because it would endanger their massive profits. 
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

GREED WATCH: Bristol Myers Squibb Announces $11 Billion In Q3 Earnings Report

Bristol Myers Squibb announced it raked in $11 billion this quarter during their earnings report today. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Bristol Myers Squibb opposes Biden administration reforms that lower prescription drug prices. 

  • Eliquis, Bristol Myers Squibb’s blockbuster blood clot drug that was selected among the first ten drugs to have lower prices negotiated by Medicare, brought in $2.7 billion this quarter – a 2 percent increase over last year. 
  • Bristol Myers Squibb CEO Giovanni Caforio bragged about “the diversification of our business, the breadth of our new product portfolio and the strength of our pipeline” while his company is simultaneously suing the Biden administration to stop Medicare from negotiating lower drug prices for patients because it would endanger their massive profits. 
  • In August, Bristol Myers Squibb announced it is rewarding its shareholders with $4 billion in stock buybacks, which they expect to complete by the end of 2023. 
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits